FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yasato Komatsu

Research Profile

Chemicals & Drugs

Living Beings

Mouse
Rats

Anatomy

Concepts & Ideas

Bone Density

Disorders

Osteoporosis

Physiology

Co-author Network

Publications

TOP 3
Yuji Hataya; Yasato Komatsu; Keisuke Osaki; Teruyuki Sato; Yorihide Fukuda; Taisuke Morimoto
A case of neurofibromatosis type 1 coinciding with bilateral pheochromocytomas, multiple gastrointestinal stromal tumors, and malignant peripheral nerve sheath tumor.
Yasuo Imanishi; Wataru Ando; Jun Hashimoto; Hiroshi Kaji; Keisuke Kobayashi; Yasato Komatsu; Hajime M Koyano; Takami Miki; Akimitsu Miyauchi; Katsuhito Mori; Tomoaki Morioka; Yuki Nagata; Koichi Oba; Takatoshi Saito; Takafumi Ueda; Masaaki Inaba
Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.
Yuji Hataya; Toshihiko Kirishima; Yasato Komatsu; Hideki Chusho; Hiroyuki Shintani; Taisuke Morimoto
A case of hepatitis C-associated osteosclerosis with xanthogranulomatous cholecystitis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yasato Komatsu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Yuji Hataya; Yasato Komatsu; Keisuke Osaki; Teruyuki Sato; Yorihide Fukuda; Taisuke Morimoto
A case of neurofibromatosis type 1 coinciding with bilateral pheochromocytomas, multiple gastrointestinal stromal tumors, and malignant peripheral nerve sheath tumor.
Internal medicine (Tokyo, Japan) 2012;51(12):1531-6.
2012: Yasuo Imanishi; Wataru Ando; Jun Hashimoto; Hiroshi Kaji; Keisuke Kobayashi; Yasato Komatsu; Hajime M Koyano; Takami Miki; Akimitsu Miyauchi; Katsuhito Mori; Tomoaki Morioka; Yuki Nagata; Koichi Oba; Takatoshi Saito; Takafumi Ueda; Masaaki Inaba
Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.
Journal of bone and mineral metabolism 2012;30(1):93-9.
2011: Yuji Hataya; Toshihiko Kirishima; Yasato Komatsu; Hideki Chusho; Hiroyuki Shintani; Taisuke Morimoto
A case of hepatitis C-associated osteosclerosis with xanthogranulomatous cholecystitis.
Internal medicine (Tokyo, Japan) 2011;50(16):1703-8.
2011: Junko Fujitake; Yasato Komatsu; Yuji Hataya; Atsuko Nishikawa; Makoto Eriguchi; Haruo Mizuta; Michiyuki Hayashi
A case of Marinesco-Sjögren syndrome: MRI observations of skeletal muscles, bone metabolism, and treatment with testosterone and risedronate.
Internal medicine (Tokyo, Japan) 2011;50(2):145-9.
2010: Toshihito Fujii; Yasato Komatsu; Akihiro Yasoda; Eri Kondo; Tetsuro Yoshioka; Takuo Nambu; Naotestu Kanamoto; Masako Miura; Naohisa Tamura; Hiroshi Arai; Masashi Mukoyama; Kazuwa Nakao
Circulating C-type natriuretic peptide (CNP) rescues chondrodysplastic CNP knockout mice from their impaired skeletal growth and early death.
Endocrinology 2010;151(9):4381-8.
2010: Akira Ishii; Yasuo Imanishi; Keisuke Kobayashi; Jun Hashimoto; Takafumi Ueda; Akimitsu Miyauchi; Hajime M Koyano; Hiroshi Kaji; Takatoshi Saito; Koichi Oba; Yasato Komatsu; Masafumi Kurajoh; Yuki Nagata; Hitoshi Goto; Kenichi Wakasa; Toshitsugu Sugimoto; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
The levels of somatostatin receptors in causative tumors of oncogenic osteomalacia are insufficient for their agonist to normalize serum phosphate levels.
Calcified tissue international 2010;86(6):455-62.
2009: Akihiro Yasoda; Hidetomo Kitamura; Toshihito Fujii; Eri Kondo; Naoaki Murao; Masako Miura; Naotetsu Kanamoto; Yasato Komatsu; Hiroshi Arai; Kazuwa Nakao
Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.
Endocrinology 2009;150(7):3138-44.
2009: Takafumi Majima; Akira Shimatsu; Yasato Komatsu; Noriko Satoh; Atsushi Fukao; Kiyoshi Ninomiya; Tadashi Matsumura; Kazuwa Nakao
Effects of risedronate or alfacalcidol on bone mineral density, bone turnover, back pain, and fractures in Japanese men with primary osteoporosis: results of a two-year strict observational study.
Journal of bone and mineral metabolism 2009;27(2):168-74.
2008: Hiroshi Arai; Nozomi Kobayashi; Yuko Nakatsuru; Hiroaki Masuzaki; Takuo Nambu; Kazuhiko Takaya; Yusuke Yamanaka; Eri Kondo; Go Yamada; Toshihito Fujii; Masako Miura; Yasato Komatsu; Naotetsu Kanamoto; Hiroyuki Ariyasu; Kenji Moriyama; Akihiro Yasoda; Kazuwa Nakao
A case of cortisol producing adrenal adenoma without phenotype of Cushing's syndrome due to impaired 11beta-hydroxysteroid dehydrogenase 1 activity.
Endocrine journal 2008;55(4):709-15.
2008: Takafumi Majima; Yasato Komatsu; Akira Shimatsu; Noriko Satoh; Atsushi Fukao; Kiyoshi Ninomiya; Tadashi Matsumura; Kazuwa Nakao
Efficacy of combined treatment with raloxifene and alfacalcidol on bone density and biochemical markers of bone turnover in postmenopausal osteoporosis.
Endocrine journal 2008;55(1):127-34.
2008: Takafumi Majima; Akira Shimatsu; Yasato Komatsu; Noriko Satoh; Atsushi Fukao; Kiyoshi Ninomiya; Tadashi Matsumura; Kazuwa Nakao
Increased bone turnover in patients with hypercholesterolemia.
Endocrine journal 2008;55(1):143-51.
2008: Takafumi Majima; Akira Shimatsu; Yasato Komatsu; Noriko Satoh; Atsushi Fukao; Kiyoshi Ninomiya; Tadashi Matsumura; Kazuwa Nakao
Association between baseline values of bone turnover markers and bone mineral density and their response to raloxifene treatment in Japanese postmenopausal women with osteoporosis.
Endocrine journal 2008;55(1):41-8.
2008: Takafumi Majima; Akira Shimatsu; Yasato Komatsu; Noriko Satoh; Atsushi Fukao; Kiyoshi Ninomiya; Tadashi Matsumura; Kazuwa Nakao
Efficacy of risedronate in Japanese male patients with primary osteoporosis.
Internal medicine (Tokyo, Japan) 2008;47(8):717-23.
2008: Takafumi Majima; Akira Shimatsu; Noriko Satoh; Yasato Komatsu; Atsushi Fukao; Kiyoshi Ninomiya; Tadashi Matsumura; Kazuwa Nakao
Three-month changes in bone turnover markers and bone mineral density response to raloxifene in Japanese postmenopausal women with osteoporosis.
Journal of bone and mineral metabolism 2008;26(2):178-84.
2007: Yasato Komatsu
[Parathyroid and bone. Medical management of primary hyperparathyroidism].
Clinical calcium 2007;17(12):1902-8.
2007: Takafumi Majima; Yasato Komatsu; Akira Shimatsu; Noriko Satoh; Atsushi Fukao; Kiyoshi Ninomiya; Tadashi Matsumura; Kazuwa Nakao
Clinical significance of 1-year treatment with raloxifene on bone and lipid metabolism in Japanese postmenopausal women with osteoporosis.
Endocrine journal 2007;54(6):855-62.
2007: Takafumi Majima; Yasato Komatsu; Atsushi Fukao; Kiyoshi Ninomiya; Tadashi Matsumura; Kazuwa Nakao
Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia.
Endocrine journal 2007;54(1):145-51.
2007: Takafumi Majima; Akira Shimatsu; Yasato Komatsu; Noriko Satoh; Atsushi Fukao; Kiyoshi Ninomiya; Tadashi Matsumura; Kazuwa Nakao
Short-term effects of pitavastatin on biochemical markers of bone turnover in patients with hypercholesterolemia.
Internal medicine (Tokyo, Japan) 2007;46(24):1967-73.
2006: Yasato Komatsu; Takafumi Majima
[Negative correlation between BMD and HbA1C in patients with type 2 diabetes].
Clinical calcium 2006;16(8):1327-31.
2006: Takafumi Majima; Yasato Komatsu; Kentaro Doi; Michika Shigemoto; Chieko Takagi; Atsushi Fukao; Jerry Corners; Kazuwa Nakao
Safety and efficacy of low-dose pioglitazone (7.5 mg/day) vs. standard-dose pioglitazone (15 mg/day) in Japanese women with type 2 diabetes mellitus.
Endocrine journal 2006;53(3):325-30.
2006: Naoshi Nishida; Yasato Komatsu; Toshiki Komeda; Yoshihiro Fukuda
Interferon-alpha improves bone resorption and osteopenia in patients with chronic hepatitis C.
Hepatology research : the official journal of the Japan Society of Hepatology 2006;34(4):222-7.
2006: Takafumi Majima; Yasato Komatsu; Kentaro Doi; Chieko Takagi; Michika Shigemoto; Atsushi Fukao; T Morimoto; Jerry Corners; Kazuwa Nakao
Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves' disease.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2006;17(7):1103-10.
2006: Takafumi Majima; Yasato Komatsu; Kentaro Doi; Chieko Takagi; Michika Shigemoto; Atsushi Fukao; Takeshi Morimoto; Jerry Corners; Kazuwa Nakao
Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease.
Journal of bone and mineral metabolism 2006;24(2):105-13.
2005: Takuo Nambu; Hiroshi Arai; Yasato Komatsu; Akihiro Yasoda; Kenji Moriyama; Naotetsu Kanamoto; Hiroshi Itoh; Kazuwa Nakao
Expression of the adrenomedullin gene in adipose tissue.
Regulatory peptides 2005;132(1-3):17-22.
2005: Takafumi Majima; Yasato Komatsu; Kentaro Doi; Michika Shigemoto; Chieko Takagi; Atsushi Fukao; Masatsugu Kojima; Hisanobu Tamaki; Juichi Ito; Kazuwa Nakao
Anaplastic thyroid carcinoma associated with Graves' disease.
Endocrine journal 2005;52(5):551-7.
2005: Takafumi Majima; Yasato Komatsu; T Yamada; Y Koike; Michika Shigemoto; Chieko Takagi; I Hatanaka; Kazuwa Nakao
Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(8):907-13.
2005: Takafumi Majima; Kentaro Doi; Yasato Komatsu; Hiroshi Itoh; Atsushi Fukao; Michika Shigemoto; Chieko Takagi; Jerry Corners; Naomi Mizuta; Ryohei Kato; Kazuwa Nakao
Papillary thyroid carcinoma without metastases manifesting as an autonomously functioning thyroid nodule.
Endocrine journal 2005;52(3):309-16.
2005: Ami Ozasa; Yasato Komatsu; Akihiro Yasoda; Masako Miura; Yoko Sakuma; Yuko Nakatsuru; Hiroshi Arai; Nobuyuki Itoh; Kazuwa Nakao
Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.
Bone 2005;36(6):1056-64.
2005: Sumiko Furuto-Kato; Shigeru Matsukura; Makoto Ogata; Nobuyuki Azuma; Toshiaki Manabe; Chohei Shigeno; Ryo Asato; Kiyoshi Tanaka; Yasato Komatsu; Kazuwa Nakao
Primary hyperparathyroidism presumably caused by chronic parathyroiditis manifesting from hypocalcemia to severe hypercalcemia.
Internal medicine (Tokyo, Japan) 2005;44(1):60-4.
2004: Yasato Komatsu; Kazuwa Nakao
[Ghrelin and bone metabolism].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 9():384-7.
2004: Akihiro Yasoda; Yasato Komatsu; Kazuwa Nakao; Yoshihiro Ogawa
[Growth promoting effect of natriuretic peptides on bones formed through endochondral ossification].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 9():60-4.
2004: Yasato Komatsu; Kazuwa Nakao
[Stimulation of bone formation by statins].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 2():783-8.
2004: Akihiro Yasoda; Yasato Komatsu; Kazuwa Nakao; Yoshihiro Ogawa
[C-type natriuretic peptide(CNP)--a novel stimulator of bone growth formed through endochondral ossification].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 2():77-81.
2004: Akihiro Yasoda; Yasato Komatsu; Hideki Chusho; Takashi Miyazawa; Ami Ozasa; Masako Miura; Tatsuya Kurihara; Tomohiro Rogi; Shoji Tanaka; Michio Suda; Naohisa Tamura; Yoshihiro Ogawa; Kazuwa Nakao
Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.
Nature medicine 2004;10(1):80-6.
2003: Yasato Komatsu; Akihiro Yasoda; Hideki Chusho; Kazuwa Nakao
[The possible novel treatment of achondroplasia, C-type natriuretic peptide (CNP)].
Clinical calcium 2003;13(12):1578-81.
2003: Yasato Komatsu; Ran Nakajima; Akihiro Yasoda; Yuko Nakatsuru; Hiroshi Arai; Kazuwa Nakao; Chohei Shigeno
[In Process Citation].
Clinical calcium 2003;13(9):1188-92.
2003: Shinji Kaihara; Kazuhisa Bessho; Yasunori Okubo; Junya Sonobe; Yasato Komatsu; Masako Miura; Shin-Ichi Miyatake; Kazuwa Nakao; Tadahiko Iizuka
Over expression of bone morphogenetic protein-3b (BMP-3b) using an adenoviral vector promote the osteoblastic differentiation in C2C12 cells and augment the bone formation induced by bone morphogenetic protein-2 (BMP-2) in rats.
Life sciences 2003;72(15):1683-93.
2002: Takeshi Fujisawa; Yasato Komatsu; Akihiro Yasoda; Masako Miura; Ami Ozasa; Shinji Kosugi; Hroomi Okamoto; Yoshitaka Konda; Kimio Kawasaki; Tsutomu Chiba; Kazuwa Nakao
[In Process Citation].
Clinical calcium 2002;12(11):1576-9.
2002: Takashi Miyazawa; Yoshihiro Ogawa; Hideki Chusho; Akihiro Yasoda; Naohisa Tamura; Yasato Komatsu; Alexander Pfeifer; Franz Hofmann; Kazuwa Nakao
Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification.
Endocrinology 2002;143(9):3604-10.
2002: Masako Miura; Kiyoshi Tanaka; Yasato Komatsu; Michio Suda; Akihiro Yasoda; Yoko Sakuma; Ami Ozasa; Kazuwa Nakao
A novel interaction between thyroid hormones and 1,25(OH)(2)D(3) in osteoclast formation.
Biochemical and biophysical research communications 2002;291(4):987-94.
2002: Masako Miura; Kiyoshi Tanaka; Yasato Komatsu; Michio Suda; Akihiro Yasoda; Yoko Sakuma; Ami Ozasa; Kazuwa Nakao
Thyroid hormones promote chondrocyte differentiation in mouse ATDC5 cells and stimulate endochondral ossification in fetal mouse tibias through iodothyronine deiodinases in the growth plate.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17(3):443-54.
2002: Yasato Komatsu; Hideki Chusho; Naohisa Tamura; Akihiro Yasoda; Takashi Miyazawa; Michio Suda; Masako Miura; Yoshihiro Ogawa; Kazuwa Nakao
Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice.
Journal of bone and mineral metabolism 2002;20(6):331-6.
2002: Michio Suda; Kiyoshi Tanaka; Akihiro Yasoda; Yasato Komatsu; Hideki Chusho; Masako Miura; Naohisa Tamura; Yoshihiro Ogawa; Kazuwa Nakao
C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line.
Journal of bone and mineral metabolism 2002;20(3):136-41.
2001: Hideki Chusho; Naohisa Tamura; Yoshihiro Ogawa; Akihiro Yasoda; Michio Suda; Takashi Miyazawa; Kozo Nakamura; Kazuwa Nakao; Tatsuo Kurihara; Yasato Komatsu; Hiroaki Itoh; Kiyoji Tanaka; Yoshihiko Saito; M Katsuki; K Nakao
Dwarfism and early death in mice lacking C-type natriuretic peptide.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(7):4016-21.
2000: Kazuhiko Takaya; Hiroyuki Ariyasu; Naotetsu Kanamoto; Hiroshi Iwakura; Akihiro Yoshimoto; M Harada; Kazuhiro J Mori; Yasato Komatsu; Takeshi Usui; Akira Shimatsu; Yoshihiro Ogawa; Kiminori Hosoda; Takashi Akamizu; Masayasu Kojima; Kenji Kangawa; Kazuwa Nakao
Ghrelin strongly stimulates growth hormone release in humans.
The Journal of clinical endocrinology and metabolism 2000;85(12):4908-11.
2000: Yoko Sakuma; Kiyoji Tanaka; Michio Suda; Yasato Komatsu; Akihiro Yasoda; Masako Miura; Ami Ozasa; Shuh Narumiya; Yukihiko Sugimoto; Atsushi Ichikawa; Fumitaka Ushikubi; Kazuwa Nakao
Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype.
Infection and immunity 2000;68(12):6819-25.
2000: Hideki Chusho; Yoshihiro Ogawa; Naohisa Tamura; Michio Suda; Akihiro Yasoda; Takashi Miyazawa; Ichiro Kishimoto; Yasato Komatsu; Hiroaki Itoh; Kiyoji Tanaka; Yoshihiko Saito; David L Garbers; Kazuwa Nakao
Genetic models reveal that brain natriuretic peptide can signal through different tissue-specific receptor-mediated pathways.
Endocrinology 2000;141(10):3807-13.
1999: Michio Suda; Yasato Komatsu; Kiyoji Tanaka; Akihiro Yasoda; Yoko Sakuma; Naohisa Tamura; Yoshihiro Ogawa; Kazuwa Nakao
C-Type natriuretic peptide/guanylate cyclase B system in rat osteogenic ROB-C26 cells and its down-regulation by dexamethazone.
Calcified tissue international 1999;65(6):472-8.
1998: Shinichi Suga; Hiroaki Itoh; Yasato Komatsu; H Ishida; T Igaki; Jun K Yamashita; Kentaro Doi; Tae-Hwa Chun; T Yoshimasa; Issei Tanaka; Kazuwa Nakao
Regulation of endothelial production of C-type natriuretic peptide by interaction between endothelial cells and macrophages.
Endocrinology 1998;139(4):1920-6.
1998: T Igaki; Hiroaki Itoh; Shinichi Suga; N Hama; Yoshihiro Ogawa; Yasato Komatsu; Jun K Yamashita; Kentaro Doi; Tae-Hwa Chun; Kazuwa Nakao
Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide.
Hypertension research : official journal of the Japanese Society of Hypertension 1998;21(1):7-13.
1997: Hiroaki Itoh; Shinichi Suga; Yoshihiro Ogawa; Yasato Komatsu; Naohisa Tamura; T Igaki; Jun K Yamashita; Tadashi Ikeda; Kentaro Doi; Tae-Hwa Chun; Mayumi Inoue; K Matsuda; T Yoshimasa; Masamichi Ueda; T Ban; Kazuwa Nakao
Significance of vascular natriuretic peptide system in vascular remodeling in humans and its application to gene therapy.
Annals of the New York Academy of Sciences 1997;811():533-41.
1996: T Igaki; H Itoh; Shinichi Suga; Yasato Komatsu; Yoshihiro Ogawa; Kentaro Doi; T Yoshimasa; Kazuwa Nakao
Insulin suppresses endothelial secretion of C-type natriuretic peptide, a novel endothelium-derived relaxing peptide.
Diabetes 1996;45 Suppl 3():S62-4.
1996: Michio Suda; K Tanaka; M Fukushima; Koshi Natsui; Akihiro Yasoda; Yasato Komatsu; Yoshihiro Ogawa; H Itoh; Kazuwa Nakao
C-type natriuretic peptide as an autocrine/paracrine regulator of osteoblast. Evidence for possible presence of bone natriuretic peptide system.
Biochemical and biophysical research communications 1996;223(1):1-6.
1996: T Igaki; H Itoh; Shinichi Suga; N Hama; Yoshihiro Ogawa; Yasato Komatsu; Masashi Mukoyama; Akira Sugawara; T Yoshimasa; Issei Tanaka; Kazuwa Nakao
C-type natriuretic peptide in chronic renal failure and its action in humans.
Kidney international. Supplement 1996;55():S144-7.
1996: Yasato Komatsu; H Itoh; Shinichi Suga; T Igaki; Yoshihiro Ogawa; I Kishimoto; O Nakagawa; T Yoshimasa; Kazuwa Nakao
Regulation of secretion and clearance of C-type natriuretic peptide in the interaction of vascular endothelial cells and smooth muscle cells.
Journal of hypertension 1996;14(5):585-92.
1996: Yasato Komatsu; H Itoh; Shinichi Suga; Yoshihiro Ogawa; N Hama; I Kishimoto; O Nakagawa; T Igaki; Kentaro Doi; T Yoshimasa; Kazuwa Nakao
Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells. Role of the vascular natriuretic peptide system in vascular growth inhibition.
Circulation research 1996;78(4):606-14.
1996: Tadashi Ikeda; H Itoh; Yasato Komatsu; M Hanyu; T Yoshimasa; K Matsuda; Kazuwa Nakao; T Ban
Natriuretic peptide receptors in human artery and vein and rabbit vein graft.
Hypertension 1996;27(3 Pt 2):833-7.
1996: Kentaro Doi; H Itoh; Yasato Komatsu; T Igaki; Tae-Hwa Chun; K Takaya; Jun K Yamashita; Mayumi Inoue; T Yoshimasa; Kazuwa Nakao
Vascular endothelial growth factor suppresses C-type natriuretic peptide secretion.
Hypertension 1996;27(3 Pt 2):811-5.
1995: I Kishimoto; T Yoshimasa; Hidenori Arai; Kazuhiko Takaya; Yoshihiro Miyamoto; Jun K Yamashita; Shinichi Suga; Yasato Komatsu; O Nakagawa; Issei Tanaka
Endothelin-induced activation of mitogen-activated protein kinases in glomerular mesangial cells from normotensive and stroke-prone spontaneously hypertensive rats.
Clinical and experimental pharmacology & physiology. Supplement 1995;22(1):S207-8.
1995: O Nakagawa; H Itoh; M Harada; Yasato Komatsu; T Yoshimasa; Kazuwa Nakao
Gene regulation of brain natriuretic peptide in cardiocyte hypertrophy by alpha1-adrenergic stimulation.
Clinical and experimental pharmacology & physiology. Supplement 1995;22(1):S183-5.
1995: O Nakagawa; Yoshihiro Ogawa; H Itoh; Shinichi Suga; Yasato Komatsu; I Kishimoto; K Nishino; T Yoshimasa; Kazuwa Nakao
Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.
The Journal of clinical investigation 1995;96(3):1280-7.
1994: I Kishimoto; T Yoshimasa; Shinichi Suga; Yoshihiro Ogawa; Yasato Komatsu; O Nakagawa; H Itoh; Kazuwa Nakao
Natriuretic peptide clearance receptor is transcriptionally down-regulated by beta 2-adrenergic stimulation in vascular smooth muscle cells.
The Journal of biological chemistry 1994;269(45):28300-8.
1994: Naohisa Tamura; Yoshihiro Ogawa; H Itoh; Hidenori Arai; Shinichi Suga; O Nakagawa; Yasato Komatsu; I Kishimoto; Kazuhiko Takaya; T Yoshimasa
Molecular cloning of hamster brain and atrial natriuretic peptide cDNAs. Cardiomyopathic hamsters are useful models for brain and atrial natriuretic peptides.
The Journal of clinical investigation 1994;94(3):1059-68.
1994: H Itoh; Norimasa Sagawa; M Hasegawa; H Nanno; F Kobayashi; Yu Ihara; T Mori; Yasato Komatsu; Shinichi Suga; T Yoshimasa
Expression of biologically active receptors for natriuretic peptides in the human uterus during pregnancy.
Biochemical and biophysical research communications 1994;203(1):602-7.
1994: N Hama; H Itoh; Shinichi Suga; Yasato Komatsu; T Yoshimasa; Kazuwa Nakao
A monoclonal antibody to C-type natriuretic peptide--preparation and application to radioimmunoassay and neutralization experiment.
The Journal of endocrinology 1994;141(3):473-9.
1994: N Hama; H Itoh; Gotaro Shirakami; Shinichi Suga; Yasato Komatsu; T Yoshimasa; Issei Tanaka; Kazuhiro J Mori; Kazuwa Nakao
Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients.
Biochemical and biophysical research communications 1994;198(3):1177-82.
1993: Shinichi Suga; H Itoh; Yasato Komatsu; Yoshihiro Ogawa; N Hama; T Yoshimasa; Kazuwa Nakao
Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells--evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells.
Endocrinology 1993;133(6):3038-41.
1993: Gotaro Shirakami; H Itoh; Shinichi Suga; Yasato Komatsu; N Hama; Kazuhiro J Mori; Kazuwa Nakao
Central action of C-type natriuretic peptide on vasopressin secretion in conscious rats.
Neuroscience letters 1993;159(1-2):25-8.
1992: Shinichi Suga; Kazuwa Nakao; H Itoh; Yasato Komatsu; Yoshihiro Ogawa; N Hama; Hiroshi Imura
Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".
The Journal of clinical investigation 1992;90(3):1145-9.
1992: Shinichi Suga; Kazuwa Nakao; I Kishimoto; Kiminori Hosoda; Masashi Mukoyama; Hidenori Arai; Gotaro Shirakami; Yoshihiro Ogawa; Yasato Komatsu; O Nakagawa
Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells.
Circulation research 1992;71(1):34-9.
1992: Yoshihiro Ogawa; Kazuwa Nakao; O Nakagawa; Yasato Komatsu; Kiminori Hosoda; Shinichi Suga; Hidenori Arai; K Nagata; N Yoshida; Hiroshi Imura
Human C-type natriuretic peptide. Characterization of the gene and peptide.
Hypertension 1992;19(6 Pt 2):809-13.
1992: S Hori; Yasato Komatsu; R Shigemoto; N Mizuno; Shigetada Nakanishi
Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors.
Endocrinology 1992;130(4):1885-95.
1991: Yasato Komatsu; Kazuwa Nakao; Shinichi Suga; Yoshihiro Ogawa; Masashi Mukoyama; Hidenori Arai; Gotaro Shirakami; Kiminori Hosoda; O Nakagawa; N Hama
C-type natriuretic peptide (CNP) in rats and humans.
Endocrinology 1991;129(2):1104-6.